News for Healthier Living
The Lancet Publishes Landmark Trial of Duchenne Muscular Dystrophy Therapy
An investigational cell therapy preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy, according to Phase III clinical trial results from Cedars-Sinai Health Sciences University investigators and colleagues published in The Lancet.
July 29, 2026
July 29 2026July 28 2026July 27 2026July 26 2026July 25 2026July 24 2026July 23 2026July 22 2026July 21 2026July 20 2026July 17 2026July 16 2026
|
|
|
|
|